Dosage of rituximab in systemic sclerosis: 2‐year results of five cases

E-ISSN： 1365-2230|40|2|211-212

ISSN： 0307-6938

Source： CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol.40, Iss.2, 2015-03, pp. : 211-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Cheyne-Stokes Respiration in Congestive Heart Failure: Continuous Positive Airway Pressure of 5–8 cm H₂O for 1 Year in Five Cases

Respiration, Vol. 72, Iss. 2, 2005-04 ,pp. : 198-201

Karger

Access to resources Recommend Favorite

Systemic sclerosis

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 2, 2018-02 ,pp. : 128-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of Treatment with Rituximab (Anti-CD20) in Three Patients with Autoimmune Hemolytic Anemia and/or Immune Thrombocytopenia and a Concise Review of Reported Cases

Transfusion Medicine and Hemotherapy, Vol. 29, Iss. 5, 2002-10 ,pp. : 277-281

Karger

Access to resources Recommend Favorite

Parental Influence on Systemic Sclerosis

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 2, 2015-02 ,pp. : 310-312

John Wiley & Sons Inc

Access to resources Recommend Favorite